MGM Mirage (MGM) Shares Higher Amid Upgrade at Citi
Tweet Send to a Friend
Get Alerts MGM Hot Sheet
Price: $15.54 --0%
Rating Summary:
14 Buy, 13 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 20 | New: 11
Rating Summary:
14 Buy, 13 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 20 | New: 11
Trade MGM Now!
Shares of MGM Mirage (NYSE: MGM) are trading higher this morning as an analyst at Citi upgraded the stock from Sell to Hold earlier. The firm boosted its price target on the stock from $11 to $16.60.
MGM shares are up 1.4% to $16.53 today. Elsewhere in the sector, shares of Las Vegas Sands (NYSE: LVS) are up 1.1% to $47.71 and Wynn (Nasdaq: WYNN) shares are up 0.5% to $117.36.
For more ratings news on MGM Mirage click here and for the rating history of MGM Mirage click here.
Shares of MGM Mirage closed at $16.29 yesterday, with a 52 week range of $8.92-$16.85.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
MGM shares are up 1.4% to $16.53 today. Elsewhere in the sector, shares of Las Vegas Sands (NYSE: LVS) are up 1.1% to $47.71 and Wynn (Nasdaq: WYNN) shares are up 0.5% to $117.36.
For more ratings news on MGM Mirage click here and for the rating history of MGM Mirage click here.
Shares of MGM Mirage closed at $16.29 yesterday, with a 52 week range of $8.92-$16.85.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- The ExOne Company (XONE) Metal Opportunity to Keep Stock Going - FBR
- Macquarie Upgrades IntercontinentalExchange (ICE) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

